These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7033154)

  • 21. Experimental examinations on the suitability of organoaminomethane-bis-phosphonic acids for bone-scintigraphy by means of Tc-99m in animals.
    Unterspann S
    Eur J Nucl Med; 1976 Aug; 1(3):151-4. PubMed ID: 1024826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of 99mTe-Sn-EHDP in beagles with advanced periodontal disease.
    Kaplan ML; Garcia DA; Goldhaber P; Davis MA; Adelstein SJ
    Calcif Tissue Res; 1975 Dec; 19(2):91-8. PubMed ID: 1203751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characterization of a bridged 99Tc-Sn-dimethylglyoxime complex: implications for the chemistry of 99mTc-radiopharmaceuticals prepared by the Sn (II) reduction of pertechnetate.
    Deutsch E; Elder RC; Lange BA; Vaal MJ; Lay DG
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4287-9. PubMed ID: 1069984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tin--a new radioisotope for bone scintigraphy].
    Kutzner J
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:71-2. PubMed ID: 4341238
    [No Abstract]   [Full Text] [Related]  

  • 25. The importance of the chemical state of 99mTc radiopharmaceuticals: an effective tumor imaging form of 99mTc bleomycin.
    Yokoyama A; Terauchi Y; Horiuchi K; Okumura S; Saito Y; Tanaka H; Odori T; Morita R; Mori T; Torizuka K
    Int J Appl Radiat Isot; 1978 Oct; 29(9-10):549-55. PubMed ID: 85607
    [No Abstract]   [Full Text] [Related]  

  • 26. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stannous pyrophosphate labeled with technetium-99m for skeletal scintigraphy.
    Hégésippe M; Beydon J; Bardy A; Pannecière C
    J Nucl Biol Med; 1973; 17(3):93-6. PubMed ID: 4355660
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo inorganic chemistry of technetium cations.
    Deutsch E; Hirth W
    J Nucl Med; 1987 Sep; 28(9):1491-500. PubMed ID: 3305808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
    Bombardieri E; Setti L; Kirienko M; Antunovic L; Guglielmo P; Ciocia G
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):381-99. PubMed ID: 26337240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic accumlation of 99mTc-Sn-diphosphonate].
    Hayashi S; Oyama K; Hirakawa K; Akaike A; Kogure T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1977 Aug; 37(8):784-90. PubMed ID: 917749
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complexation behavior and biodistribution in the rat of 99mTc-labeled aminoalkylphosphonic acids].
    Libera T; Unterspann S; Finck W
    Radiobiol Radiother (Berl); 1988; 29(2):207-10. PubMed ID: 3399658
    [No Abstract]   [Full Text] [Related]  

  • 32. Radioisotopic evaluation of skeletal disease.
    Kirchner PT; Simon MA
    J Bone Joint Surg Am; 1981 Apr; 63(4):673-81. PubMed ID: 7217134
    [No Abstract]   [Full Text] [Related]  

  • 33. Nuclear medicine: an overview.
    Leonard JC
    South Med J; 1978 Jun; 71(6):709-14. PubMed ID: 663701
    [No Abstract]   [Full Text] [Related]  

  • 34. The diagnostic efficiacy of bone-seeking agents.
    Creutzig H
    Eur J Nucl Med; 1983; 8(5):232. PubMed ID: 6873100
    [No Abstract]   [Full Text] [Related]  

  • 35. Valence state of technetium in technetium methylene diphosphonate at tracer concentrations, measured by amperometry.
    Mulder G; Oldenburg SJ; van Oort WJ; den Hartigh JD
    Int J Appl Radiat Isot; 1981 Sep; 32(9):675-7. PubMed ID: 6457808
    [No Abstract]   [Full Text] [Related]  

  • 36. A new method for radionuclide imaging of myocardial infarcts.
    Bonte FJ; Parkey RW; Graham KD; Moore J; Stokely EM
    Radiology; 1974 Feb; 110(2):473-4. PubMed ID: 4359008
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
    Yang JS
    Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
    [No Abstract]   [Full Text] [Related]  

  • 38. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
    Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
    J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
    [No Abstract]   [Full Text] [Related]  

  • 39. The determination of methylene diphosphonic acid in lyophilized radiopharmaceuticals.
    Barnes RK; Isaacs SR
    Int J Appl Radiat Isot; 1981 Mar; 32(3):174-5. PubMed ID: 6456230
    [No Abstract]   [Full Text] [Related]  

  • 40. Technetium 99m labeled diphosphonate bone scanning in Paget's disease.
    Miller SW; Castronovo FP; Pendergrass HP; Potsaid MS
    Am J Roentgenol Radium Ther Nucl Med; 1974 May; 121(1):177-83. PubMed ID: 4833906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.